Active, Not Recruiting
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)
NCT05522231
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
- Beijing Chao-Yang Hospital, Capital Medical University Beijing, China
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- Peking Union Medical College Hospital Beijing, China
- Peking University First Hospital Beijing, China